1274P First-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) in Asian patients (pts) with advanced non-small cell lung cancer (aNSCLC) in CheckMate 227
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2020 31 Supplement 4:S824-S824 - Subject
- Language
- ISSN
- 0923-7534